Malaikannan(Malai) Sankarasubbu
Malaikannan Sankarasubbu is the Vice President of Engineering and Research at Saama. During his time with the company, Malai led Saama's development of Smart Data Quality (SDQ), a smart application that was leveraged in creating Pfizer's COVID-19 vaccine.
His findings regarding the pandemic research were compiled for the 36th annual ACM Symposium on Applied Commuting. Since 2021, Malai has been cited nearly 60 times in scholarly peer-reviewed artificial intelligence articles. With 18 years of experience in software product development and 5 years at Saama, Malai's contributions have improved the effectiveness and efficiency of clinical trials through the development of AI tools.
Malai's past recognitions include the prestigious Pharmavoice Top 100 Change Agent in 2021, the PM360 Data Miner award, and a Distinguished Alumni Award from his alma mater.
His findings regarding the pandemic research were compiled for the 36th annual ACM Symposium on Applied Commuting. Since 2021, Malai has been cited nearly 60 times in scholarly peer-reviewed artificial intelligence articles. With 18 years of experience in software product development and 5 years at Saama, Malai's contributions have improved the effectiveness and efficiency of clinical trials through the development of AI tools.
Malai's past recognitions include the prestigious Pharmavoice Top 100 Change Agent in 2021, the PM360 Data Miner award, and a Distinguished Alumni Award from his alma mater.
